Taysha Gene Therapies, Inc. (TSHA)
NASDAQ: TSHA · Real-Time Price · USD
2.380
-0.030 (-1.24%)
At close: Jun 27, 2025, 4:00 PM
2.360
-0.020 (-0.82%)
After-hours: Jun 27, 2025, 5:13 PM EDT
Taysha Gene Therapies Market Cap
Taysha Gene Therapies has a market cap or net worth of $510.89 million as of June 27, 2025. Its market cap has decreased by -24.54% in one year.
Market Cap
510.89M
Enterprise Value
455.93M
1-Year Change
-24.54%
Ranking
Category
Stock Price
$2.38
Market Cap Chart
Since the IPO on September 24, 2020, Taysha Gene Therapies's market cap has decreased from $690.43M to $510.89M, a decrease of -26.00%. That is a compound annual growth rate of -6.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2025 | 551.68M | 55.60% |
| Dec 31, 2024 | 354.55M | 7.14% |
| Dec 29, 2023 | 330.92M | 134.50% |
| Dec 30, 2022 | 141.12M | -68.52% |
| Dec 31, 2021 | 448.22M | -55.28% |
| Dec 31, 2020 | 1.00B | 45.15% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 712.32B |
| Johnson & Johnson | 367.19B |
| AbbVie | 328.55B |
| Novo Nordisk | 313.40B |
| UnitedHealth Group | 274.28B |
| Abbott Laboratories | 239.47B |
| Novartis AG | 232.39B |
| AstraZeneca | 218.32B |